Lippia graveolens Essential Oil to Enhance the Effect of Imipenem against Axenic and Co-Cultures of Pseudomonas aeruginosa and Acinetobacter baumannii
- PMID: 38786172
- PMCID: PMC11117758
- DOI: 10.3390/antibiotics13050444
Lippia graveolens Essential Oil to Enhance the Effect of Imipenem against Axenic and Co-Cultures of Pseudomonas aeruginosa and Acinetobacter baumannii
Abstract
This research focuses on assessing the synergistic effects of Mexican oregano (Lippia graveolens) essential oil or carvacrol when combined with the antibiotic imipenem, aiming to reduce the pathogenic viability and virulence of Acinetobacter baumannii and Pseudomonas aeruginosa. The study highlighted the synergistic effect of combining L. graveolens essential oil or carvacrol with imipenem, significantly reducing the required doses for inhibiting bacterial growth. The combination treatments drastically lowered the necessary imipenem doses, highlighting a potent enhancement in efficacy against A. baumannii and P. aeruginosa. For example, the minimum inhibitory concentrations (MIC) for the essential oil/imipenem combinations were notably low, at 0.03/0.000023 mg/mL for A. baumannii and 0.0073/0.000023 mg/mL for P. aeruginosa. Similarly, the combinations significantly inhibited biofilm formation at lower concentrations than when the components were used individually, demonstrating the strategic advantage of this approach in combating antibiotic resistance. For OXA-51, imipenem showed a relatively stable interaction during 30 ns of dynamic simulation of their interaction, indicating changes (<2 nm) in ligand positioning during this period. Carvacrol exhibited similar fluctuations to imipenem, suggesting its potential inhibition efficacy, while thymol showed significant variability, particularly at >10 ns, suggesting potential instability. With IMP-1, imipenem also displayed very stable interactions during 38 ns and demonstrated notable movement and positioning changes within the active site, indicating a more dynamic interaction. In contrast, carvacrol and thymol maintained their position within the active site only ~20 and ~15 ns, respectively. These results highlight the effectiveness of combining L. graveolens essential oil and carvacrol with imipenem in tackling the difficult-to-treat pathogens A. baumannii and P. aeruginosa.
Keywords: A. baumannii; Lippia graveolens; P. aeruginosa; carvacrol; co-cultures.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures





Similar articles
-
Inhibition of Acinetobacter baumannii Biofilm Formation by Terpenes from Oregano (Lippia graveolens) Essential Oil.Antibiotics (Basel). 2023 Oct 14;12(10):1539. doi: 10.3390/antibiotics12101539. Antibiotics (Basel). 2023. PMID: 37887240 Free PMC article.
-
The synergistic effect of Thymus vulgaris essential oil and carvacrol with imipenem against carbapenem-resistant Acinetobacter baumannii: in vitro, molecular docking, and molecular dynamics studies.Front Pharmacol. 2025 May 22;16:1582102. doi: 10.3389/fphar.2025.1582102. eCollection 2025. Front Pharmacol. 2025. PMID: 40474976 Free PMC article.
-
Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.Probiotics Antimicrob Proteins. 2024 Jun;16(3):796-814. doi: 10.1007/s12602-023-10070-w. Epub 2023 May 6. Probiotics Antimicrob Proteins. 2024. PMID: 37148452
-
Facing Resistant Bacteria with Plant Essential Oils: Reviewing the Oregano Case.Antibiotics (Basel). 2022 Dec 8;11(12):1777. doi: 10.3390/antibiotics11121777. Antibiotics (Basel). 2022. PMID: 36551436 Free PMC article. Review.
-
Imipenem-Relebactam and Meropenem-Vaborbactam: Two Novel Carbapenem-β-Lactamase Inhibitor Combinations.Drugs. 2018 Jan;78(1):65-98. doi: 10.1007/s40265-017-0851-9. Drugs. 2018. PMID: 29230684 Review.
References
-
- Centros-para-el-Control-y-la-Prevención-de-Enfermedades Preguntas y Respuestas Sobre el uso de Antibióticos. [(accessed on 3 April 2023)]; Available online: https://www.cdc.gov/antibiotic-use/sp/should-know.html.
-
- Organización Mundial de la Salud Resistencia a los Antibióticos. [(accessed on 15 June 2023)]. Available online: https://www.who.int/es/news-room/fact-sheets/detail/resistencia-a-los-an....
-
- World Health Organization WHO Outlines 40 Research Priorities on Antimicrobial Resistance. [(accessed on 19 November 2023)]. Available online: https://www.who.int/news/item/22-06-2023-who-outlines-40-research-priori....
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous